---
title: "Global and Regional Riboflavin 5-Phosphate Sodium Industry Status and Prospects Professional Market 2025-2032 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross Margin Analysis"
datePublished: Fri Oct 03 2025 01:14:33 GMT+0000 (Coordinated Universal Time)
cuid: cmga5izvr000202js0ij20nym
slug: global-and-regional-riboflavin-5-phosphate-sodium-industry-status-and-prospects-professional-market-2025-2032-capacity-production-capacity-utilization-rate-ex-factory-price-revenue-cost-gross-margin-analysis

---

# Global and Regional Riboflavin 5-Phosphate Sodium Industry Status and Prospects Professional Market 2025-2032 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross Margin Analysis

<p>
</p><p><strong>MARKET INSIGHTS</strong></p><p>
</p><div><b>Download FREE Sample of this Report @ 
            <a href="https://www.24chemicalresearch.com/download-sample/191612/global-regional-riboflavin-phosphate-sodium-market">
            https://www.24chemicalresearch.com/download-sample/191612/global-regional-riboflavin-phosphate-sodium-market</a></b></div><br><p>Global Riboflavin 5-Phosphate Sodium market size was valued at USD 56.8 million in 2024. The market is projected to grow from USD 61.3 million in 2025 to USD 92.7 million by 2032, exhibiting a CAGR of 6.1% during the forecast period.</p><p>
</p><p>Riboflavin 5-Phosphate Sodium, also known as flavin mononucleotide (FMN), is the active coenzyme form of vitamin B2 (riboflavin). This water-soluble compound plays a critical role in cellular energy production as a precursor to flavin adenine dinucleotide (FAD), which participates in various metabolic reactions including carbohydrate, protein, and fat metabolism. The product is available in different purity grades, primarily 98% and 99%, catering to pharmaceutical and chemical applications.</p><p>
</p><p>The market growth is driven by increasing demand from the pharmaceutical sector, where it's used in nutritional supplements and metabolic disorder treatments. While the chemical industry utilizes it as a precursor in specialty formulations, recent innovations in biopharmaceutical applications are creating new opportunities. However, price volatility of raw materials and stringent regulatory requirements pose challenges to market expansion.</p><p>

</p><p>
<strong>MARKET DYNAMICS</strong></p><p>
<strong>MARKET DRIVERS</strong></p><p>
</p><p style="text-align:center"><strong>Growing Pharmaceutical Applications Drive Demand for Riboflavin 5-Phosphate Sodium</strong></p><p>
</p><p>The pharmaceutical industry's increasing utilization of riboflavin 5-phosphate sodium (FMN-Na) as an essential coenzyme in metabolism and cell function is a significant market driver. FMN-Na plays a critical role in enzymatic reactions and is widely used in various therapeutic formulations. The global pharmaceutical market continues to expand, with projections indicating steady growth through 2032, creating sustained demand for high-purity FMN-Na. Recent developments in metabolic disorder treatments and neurological therapies have further amplified its importance in drug formulations.</p><p>
</p><p style="text-align:center"><strong>Rising Health Consciousness Boosts Nutraceutical Adoption</strong></p><p>
</p><p>Consumer awareness regarding preventive healthcare and nutritional supplementation has created substantial opportunities for riboflavin 5-phosphate sodium in the nutraceutical sector. As the global nutraceutical market continues its upward trajectory, FMN-Na is increasingly incorporated into dietary supplements and fortified foods. The vitamin B2 derivative's superior bioavailability compared to standard riboflavin makes it particularly valuable for nutritional applications. With preventive healthcare expenditure projected to grow significantly by 2032, this sector presents sustained demand potential.</p><p>
</p><p>Furthermore, regulatory approvals for vitamin fortification programs in developing nations are creating new market avenues. The WHO's micronutrient initiative programs have further validated the importance of riboflavin supplementation in addressing nutritional deficiencies globally.</p><p>

</p><p><strong>â¤ Clinical research continues to demonstrate FMN-Na's effectiveness in addressing riboflavin deficiency-related conditions, supporting its growing therapeutic adoption.</strong></p><p>
</p><p>Additionally, advancements in production technologies are enabling manufacturers to improve yield and purity while reducing costs, making FMN-Na more accessible across various applications.</p><p>
<strong>MARKET RESTRAINTS</strong></p><p>
</p><p style="text-align:center"><strong>High Production Costs Limit Market Penetration</strong></p><p>
</p><p>The complex synthesis process for riboflavin 5-phosphate sodium presents significant cost challenges that restrain market growth. Manufacturing pharmaceutical-grade FMN-Na requires specialized equipment and stringent quality controls, leading to higher production costs compared to standard riboflavin. These cost factors make FMN-Na less accessible in price-sensitive markets, particularly in developing regions where cost considerations significantly influence purchasing decisions.</p><p>
</p><p>The purification process alone can account for a substantial portion of total production expenses. While technological improvements are gradually reducing costs, the price premium over conventional riboflavin remains a barrier for widespread adoption in certain applications.</p><p>
</p><p style="text-align:center"><strong>Regulatory Complexity Impacts Market Expansion</strong></p><p>
</p><p>Varying international regulations governing pharmaceutical ingredients and dietary supplements create hurdles for FMN-Na manufacturers. The documentation requirements for GMP compliance and quality certifications differ significantly across regions, necessitating substantial investments in regulatory affairs. This complexity particularly affects smaller producers who may lack the resources to navigate diverse regulatory landscapes.</p><p>
</p><p>Recent updates to pharmacopeia standards in major markets have further intensified compliance requirements. While these changes improve product quality, they simultaneously increase the barriers to market entry for new participants.</p><p>
<strong>MARKET OPPORTUNITIES</strong></p><p>
</p><p style="text-align:center"><strong>Emerging Markets Present Significant Growth Potential</strong></p><p>
</p><p>Developing regions with improving healthcare infrastructure and rising disposable incomes offer substantial opportunities for FMN-Na market expansion. Countries in Southeast Asia and Africa are witnessing increased government and private sector investment in healthcare, creating favorable conditions for pharmaceutical and nutraceutical growth. The rising middle class in these regions is becoming more health-conscious, driving demand for quality nutritional supplements.</p><p>
</p><p>The pharmaceutical industry's expansion in these markets is particularly noteworthy, with local production capabilities improving and international companies establishing regional manufacturing facilities. This trend positions FMN-Na for increased adoption in both domestic and export-oriented pharmaceutical applications.</p><p>
</p><p style="text-align:center"><strong>Innovative Formulations Open New Application Areas</strong></p><p>
</p><p>Research into novel drug delivery systems and combination therapies is creating fresh opportunities for riboflavin 5-phosphate sodium. Recent developments in targeted drug delivery and sustained-release formulations have demonstrated FMN-Na's potential in specialized therapeutic applications. The compound's unique biochemical properties make it suitable for innovative pharmaceutical formulations that require precise nutrient delivery.</p><p>
</p><p>Additionally, the growing field of personalized nutrition is opening possibilities for customized FMN-Na formulations. As nutrigenomics advances, demand for precisely dosed and bioavailable nutrient forms like FMN-Na is expected to rise significantly through 2032.</p><p>
<strong>MARKET CHALLENGES</strong></p><p>
</p><p style="text-align:center"><strong>Supply Chain Vulnerabilities Impact Market Stability</strong></p><p>
</p><p>The FMN-Na market faces significant supply chain challenges, particularly regarding raw material sourcing and global distribution. Many key starting materials have limited suppliers, creating potential bottlenecks in production. Recent global events have demonstrated how logistical disruptions can significantly impact ingredient availability and pricing stability.</p><p>
</p><p>Quality control throughout the supply chain remains another critical challenge, as FMN-Na requires strict handling conditions to maintain stability. These factors necessitate careful supply chain management and create barriers for new market entrants lacking established supplier networks.</p><p>
</p><p style="text-align:center"><strong>Technological Competition from Alternative Forms</strong></p><p>
</p><p>While FMN-Na offers distinct advantages, continuous developments in riboflavin analogs and derivatives present competitive challenges. Some newer formulations promise similar bioavailability benefits at potentially lower costs, creating pricing pressure on FMN-Na products. Manufacturers must continually demonstrate FMN-Na's superior performance characteristics to maintain its premium positioning in the market.</p><p>
</p><p>Additionally, innovations in encapsulation technologies for standard riboflavin are improving its bioavailability, potentially reducing the performance gap with FMN-Na in certain applications. This technological evolution requires FMN-Na producers to emphasize their product's unique benefits through clinical validation and targeted marketing.</p><p>

</p><p>
<strong>Segment Analysis:</strong></p><p>
</p><p>
		
		
			By Type
			
				</p><p>
		
		
			By Application
			
				</p><p>
		
		
			By End User
			
				</p><p>
		
		
			By Formulation Type
			
				</p><p>

</p><p>
<strong>COMPETITIVE LANDSCAPE</strong></p><p>
<strong>Key Industry Players</strong></p><p>
</p><p style="text-align:center"><strong>Strategic Product Development and Regional Expansion Drive Market Competition</strong></p><p>
</p><p>The global riboflavin 5-phosphate sodium market features a moderately consolidated competitive landscape, with a mix of multinational corporations and specialized manufacturers vying for market share. <strong>Aceto Corporation</strong> has emerged as a dominant player, leveraging its extensive distribution network and established presence in pharmaceutical ingredient markets across North America and Europe.</p><p>
</p><p><strong>Biosynth Carbosynth</strong> and <strong>AK Scientific Inc.</strong> have strengthened their positions through continuous investments in production technology and quality control systems. These companies accounted for approximately 30% of the combined market share in 2024, primarily due to their ability to supply high-purity (99%) riboflavin 5-phosphate sodium for critical medical applications.</p><p>
</p><p>Market participants are actively pursuing several growth strategies, including:</p><p>
</p><p>Meanwhile, Chinese manufacturers including <strong>Wuhan Yuancheng Group</strong> and <strong>Shaanxi Iknow Biotechnology</strong> are gaining traction through competitive pricing strategies and improving product quality standards. Several Indian firms, particularly <strong>SynZeal Research</strong> and <strong>Pharmaffiliates</strong>, have successfully expanded their regional presence through GMP-compliant manufacturing facilities.</p><p>
<strong>List of Key Riboflavin 5-Phosphate Sodium Suppliers</strong></p><p>
</p><p>
</p><p>The market's competitive intensity is expected to increase through 2032 as companies balance cost optimization with quality improvements. Larger players are focusing on vertical integration strategies, while mid-size manufacturers are exploring niche applications in specialty chemicals and advanced nutritional formulations to differentiate their offerings.</p><p>
</p><p>
<strong>RIBOFLAVIN 5-PHOSPHATE SODIUM MARKET TRENDS</strong></p><p>
<strong>Rising Demand in Nutraceuticals and Pharmaceuticals to Drive Market Growth</strong></p><p>
</p><p>The global riboflavin 5-phosphate sodium market is projected to grow at a significant pace, driven by increasing applications in nutraceutical and pharmaceutical industries. As an active form of vitamin B2, it plays a critical role in energy metabolism and cellular function, making it essential for dietary supplements and medical formulations. The market is expected to witness a <strong>compound annual growth rate (CAGR) of 5-6% from 2024 to 2032</strong>, supported by heightened consumer awareness of nutritional deficiencies. Emerging economies are experiencing substantial demand due to improving healthcare infrastructure and government initiatives promoting essential vitamin supplementation.</p><p>
<strong>Other Trends</strong></p><p>
</p><p><strong>Expansion of Functional Food and Beverage Industry</strong></p><p>
</p><p>The functional food and beverage sector is increasingly incorporating riboflavin 5-phosphate sodium as a fortifying agent. With consumers prioritizing health-conscious products, manufacturers are enhancing nutritional profiles with bioactive ingredients. This trend is particularly strong in North America and Europe, where fortified foods account for a significant share of dietary intake. Furthermore, rising cases of riboflavin deficiency in developing regions are expected to bolster demand, as public health programs emphasize micronutrient supplementation.</p><p>
<strong>Technological Advancements in Production Methods</strong></p><p>
</p><p>Innovations in fermentation and chemical synthesis processes are reshaping the riboflavin 5-phosphate sodium industry. Companies are adopting cost-effective biotechnological methods to improve yield and purity, particularly for pharmaceutical-grade applications. Purity levels such as <strong>98% and 99% are gaining traction</strong> due to stringent regulatory standards in drug manufacturing. Additionally, collaborations between research institutions and manufacturers are accelerating the development of sustainable production techniques, reducing environmental impact while maintaining high-quality outputs.</p><p>
<strong>Rising Regulatory Scrutiny and Quality Standards</strong></p><p>
</p><p>Governments and regulatory bodies worldwide are enforcing stricter guidelines for dietary supplements and pharmaceutical excipients, influencing market players to enhance product compliance. Stringent testing protocols and Good Manufacturing Practice (GMP) certifications are becoming critical factors for suppliers. Key markets like the U.S. and Europe have implemented rigorous evaluation processes for riboflavin 5-phosphate sodium, ensuring its safety and efficacy in medical and nutritional applications. This trend is expected to continue, with manufacturers investing in quality control measures to meet evolving regulatory expectations.</p><p>

<strong>Regional Analysis: Riboflavin 5-Phosphate Sodium Market</strong></p><p>

  
    Asia-Pacific
    
      Asia-Pacific stands as the dominant region in the global Riboflavin 5-Phosphate Sodium market, driven by robust manufacturing capabilities in China and expanding pharmaceutical sectors across the area. This region benefits from cost-effective production processes, a vast network of chemical suppliers, and increasing demand for high-purity intermediates in medicine and chemical applications. Countries like China account for a significant portion of global supply, with key applications in vitamin supplements, eye care formulations, and biochemical research. The market here is propelled by rapid industrialization and growing healthcare needs, positioning it as a cornerstone for both domestic consumption and exports.
    
  
  
  
    
      Regulatory leadership</p><p>
      Regulatory bodies such as China's National Medical Products Administration (NMPA) enforce stringent standards for pharmaceutical intermediates, ensuring quality and safety in production. These guidelines foster trust in locally manufactured Riboflavin 5-Phosphate Sodium, particularly for purity levels of 98% and 99%, which supports steady market penetration in medical uses while aligning with international export requirements.
    
    
      Market dominance</p><p>
      China leads with substantial production capacity among vendors like Shaanxi Iknow Biotechnology and Wuhan Yuancheng Group, capturing a major share of the regional and global supply. This dominance stems from established supply chains and economies of scale, enabling competitive pricing for both medicine and chemical sectors, while India contributes through exporters like Pharmaffiliates.
    
    
      Growth drivers</p><p>
      Escalating demand for nutritional supplements and advanced drug formulations drives expansion, as Riboflavin 5-Phosphate Sodium serves as a vital coenzyme in metabolic processes. Furthermore, ongoing innovations in biotechnology and partnerships with global pharma firms are broadening applications, especially in targeted therapies. The post-COVID-19 emphasis on health resilience has further accelerated R&amp;D investments in the region.
    
    
      Challenges</p><p>
      While growth is strong, issues like fluctuating raw material prices and stringent international quality validations pose hurdles for smaller producers. Additionally, competition from synthetic alternatives and supply chain disruptions from global events can impact export volumes. However, strategic adaptations in sustainable sourcing are helping mitigate these pressures over the long term.
    
  
</p><p>
</p><p><strong>North America</strong></p><p>
North America maintains a steady presence in the Riboflavin 5-Phosphate Sodium market, bolstered by rigorous oversight from the U.S. Food and Drug Administration (FDA) and a focus on high-quality imports for pharmaceutical applications. The region, particularly the United States, relies on suppliers like Aceto and AK Scientific Inc. to meet demands in medicine, where the compound is essential for formulations in ophthalmology and nutritional therapies. With a strong emphasis on research and development, innovations in drug delivery systems are integrating Riboflavin 5-Phosphate Sodium more deeply into biopharmaceutical pipelines. However, dependence on Asian imports exposes the market to geopolitical risks and pricing volatility. Growth is supported by increasing consumer awareness of vitamin B2 derivatives in health supplements, though challenges include high compliance costs and competition from domestic alternatives. Looking ahead to 2032, the market here is poised for moderate expansion through enhanced regulatory harmonization and collaborations with international vendors, ensuring reliable supply for critical medical uses while navigating economic uncertainties.</p><p>
</p><p><strong>Europe</strong></p><p>
In Europe, the Riboflavin 5-Phosphate Sodium market is shaped by comprehensive regulations under the European Medicines Agency (EMA) and REACH, prioritizing safety and environmental standards in chemical and pharmaceutical production. Demand is primarily driven by applications in medicine, with a focus on high-purity grades for use in eye treatments and metabolic disorder therapies. Vendors like Biosynth Carbosynth contribute to a balanced supply chain, supporting both local manufacturing and research initiatives. The region's commitment to sustainable practices encourages the development of eco-friendly production methods, aligning with broader EU green initiatives. While the market benefits from advanced R&amp;D ecosystems in countries like Germany and the UK, it faces hurdles from Brexit-related trade adjustments and energy cost fluctuations. Nevertheless, ongoing investments in biotechnology are fostering new opportunities, particularly in personalized medicine. As the forecast extends to 2032, Europe is expected to see sustained growth through innovation and cross-border partnerships, maintaining its role as a key consumer and innovator in this niche sector.</p><p>
</p><p><strong>South America</strong></p><p>
South America's Riboflavin 5-Phosphate Sodium market is emerging, with growing interest in pharmaceutical imports to support expanding healthcare infrastructures in countries like Brazil and Argentina. The compound finds primary use in medicine for vitamin supplementation and chemical research, though adoption is tempered by economic instability and limited local production capabilities. Reliance on global suppliers, including Asian and North American vendors, underscores the region's vulnerability to currency fluctuations and import tariffs. Positive drivers include rising public health initiatives targeting nutritional deficiencies, which boost demand for Riboflavin 5-Phosphate Sodium in affordable formulations. Challenges persist in regulatory harmonization and infrastructure for quality assurance, slowing the pace of market maturation. However, increasing foreign investments in biotech could accelerate progress, creating avenues for customized applications. By 2032, the market holds potential for notable gains if economic recovery aligns with enhanced regional trade agreements, positioning South America as a gradually strengthening player in the global landscape.</p><p>
</p><p><strong>Middle East &amp; Africa</strong></p><p>
The Middle East and Africa represent a nascent yet promising market for Riboflavin 5-Phosphate Sodium, fueled by infrastructure developments and healthcare modernization efforts in nations such as the UAE and South Africa. Applications center on medicine, where the compound supports treatments for vision-related issues and nutritional enhancement programs. Supply is largely import-driven, with vendors from Asia playing a pivotal role in meeting regional needs. Growth is propelled by urbanization and government-backed wellness campaigns, yet constrained by logistical challenges, funding shortages, and varying regulatory frameworks across countries. In the Middle East, oil revenues are enabling investments in advanced pharma facilities, while Africa grapples with access disparities. Environmental considerations are gaining traction, though enforcement remains inconsistent. Looking toward 2032, the region's market trajectory depends on stable geopolitical conditions and international aid, offering long-term prospects through expanded R&amp;D and localized production to address endemic health concerns effectively.</p><p></p><p><strong>Key Report Takeaways</strong></p><p></p><p>
</p><p>
</p><p></p><p></p><p></p><p></p><p></p><p></p><p></p><p></p><p>
</p><p>This report presents a comprehensive analysis of the global and regional markets for Riboflavin 5-Phosphate Sodium, covering the period from 2024 to 2032. It includes detailed insights into the current market status and outlook across various regions and countries, with specific focus on:</p><p>
</p><p><strong>Sales, sales volume, and revenue forecasts</strong></p><p><strong>Detailed segmentation by type and application</strong></p><p>
</p><p>In addition, the report offers in-depth profiles of key industry players, including:</p><p>
</p><p>Company profiles</p><p>Product specifications</p><p>Production capacity and sales</p><p>Revenue, pricing, gross margins</p><p>Sales performance</p><p>
</p><p>It further examines the competitive landscape, highlighting the major vendors and identifying the critical factors expected to challenge market growth.</p><p>
</p><p>As part of this research, we surveyed Riboflavin 5-Phosphate Sodium companies and industry experts. The survey covered various aspects, including:</p><p>
</p><p>Revenue and demand trends</p><p>Product types and recent developments</p><p>Strategic plans and market drivers</p><p>Industry challenges, obstacles, and potential risks</p><p>
<strong>FREQUENTLY ASKED QUESTIONS:</strong></p><p>
<strong>What is the current market size of Global Riboflavin 5-Phosphate Sodium Market?</strong></p><p>
</p><p><strong>-&gt;</strong> The global Riboflavin 5-Phosphate Sodium market was valued at <strong>USD 56.8 million in 2024</strong> and is expected to reach <strong>USD 92.7 million by 2032</strong>.</p><p>
<strong>Which key companies operate in Global Riboflavin 5-Phosphate Sodium Market?</strong></p><p>
</p><p><strong>-&gt; Key players</strong> include <strong>Aceto, AK Scientific Inc, Biosynth Carbosynth, Combi-Blocks Inc, Pharmaffiliates, and Shaanxi Iknow Biotechnology</strong>, among others.</p><p>
<strong>What are the key growth drivers?</strong></p><p>
</p><p>-&gt; Key growth drivers include <strong>rising demand in pharmaceuticals for nutritional supplements, increasing prevalence of metabolic disorders, and expansion in nutraceutical applications</strong>.</p><p>
<strong>Which region dominates the market?</strong></p><p>
</p><p><strong>-&gt; East Asia</strong> is the fastest-growing region, while <strong>North America</strong> remains a dominant market.</p><p>
<strong>What are the emerging trends?</strong></p><p>
</p><p>-&gt; Emerging trends include <strong>high-purity formulations for advanced medical uses, sustainable production methods, and integration in biopharmaceutical innovations</strong>.</p>

<div><b>Get the Complete Report & TOC @ 
            <a href="https://www.24chemicalresearch.com/reports/191612/global-regional-riboflavin-phosphate-sodium-market">
            https://www.24chemicalresearch.com/reports/191612/global-regional-riboflavin-phosphate-sodium-market</a></b></div><br>
            <b>Table of Content:</b><p>Chapter 1 Industry Overview<br />
<br>1.1 Definition<br />
<br>1.2 Assumptions<br />
<br>1.3 Research Scope<br />
<br>1.4 Market Analysis by Regions<br />
<br>1.4.1 North America Market States and Outlook (2023-2028)<br />
<br>1.4.2 East Asia Market States and Outlook (2023-2028)<br />
<br>1.4.3 Europe Market States and Outlook (2023-2028)<br />
<br>1.4.4 South Asia Market States and Outlook (2023-2028)<br />
<br>1.4.5 Southeast Asia Market States and Outlook (2023-2028)<br />
<br>1.4.6 Middle East Market States and Outlook (2023-2028)<br />
<br>1.4.7 Africa Market States and Outlook (2023-2028)<br />
<br>1.4.8 Oceania Market States and Outlook (2023-2028)<br />
<br>1.4.9 South America Market States and Outlook (2023-2028)<br />
<br>1.5 Global Riboflavin 5-Phosphate Sodium Market Size Analysis from 2023 to 2028<br />
<br>1.5.1 Global Riboflavin 5-Phosphate Sodium Market Size Analysis from 2023 to 2028 by Consumption Volume<br />
<br>1.5.2 Global Riboflavin 5-Phosphate Sodium Market Size Analysis from 2023 to 2028 by Value<br />
<br>1.5.3 Global Riboflavin 5-Phosphate Sodium Price Trends Analysis from 2023 to 2028<br />
<br>1.6 COVID-19 Outbreak: Riboflavin 5-Phosphate Sodium Industry Impact<br />
<br>Chapter 2 Global Riboflavin 5-Phosphate Sodium Competition by Types, Applications, and Top Regions and Countries<br />
<br>2.1 Global Riboflavin 5-Phosphate Sodium (Volume and Value) by Type<br />
<br>2.1.1 Global Riboflavin 5-Phosphate Sodium Consumption and Market Share by Type (2017-2022)<br />
<br>2.1.2 Global Riboflavin 5-Phosphate Sodium Revenue and Market Share by Type (2017-2022)<br />
<br>2.2 Global Ribofl</p>

<div><b>Get the Complete Report & TOC @ 
            <a href="https://www.24chemicalresearch.com/reports/191612/global-regional-riboflavin-phosphate-sodium-market">
            https://www.24chemicalresearch.com/reports/191612/global-regional-riboflavin-phosphate-sodium-market</a></b></div><br>

<b>CONTACT US:</b><br>
            203A, City Vista, Fountain Road, Kharadi, Pune, India - 411014<br>
            International: +1(332) 2424 294<br>
            Asia: +91 9169162030 <br><br>
            Follow Us On LinkedIn: <a href="https://www.linkedin.com/company/24chemicalresearch/">24ChemicalResearch LinkedIn</a>